company? Let’s change
that.
Don't see your company?
Create a company profileViewRay develops advanced radiation therapy technology for the treatment of cancer.
Vivex Biomedical is a biomedical company developing implant technology and stem cell therapies.
Apex Therapeutics develops and commercializes pharmaceuticals for the treatment of cancer and ocular diseases.
Cmxtwenty focuses on developing lipid compounds for use in non-narcotic pain treatment.
Invenra is focused on developing the next generation of best-in-class biologics, with an emphasis on multispecific antibodies and their derivatives. Invenra's proprietary technologies combine our highly developable B-Body™ bispecific platform with high throughput functional screening, enabling the optimization of unprecedented numbers of bispecific antibodies in phenotypic assays. Invenra has a pipeline of immuno-oncology bispecific antibodies that are currently in preclinical studies.
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
Tissuetech offers regenerative amniotic tissue-based products for ophthalmology, optometry, musculoskeletal, and wound care markets.
Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.
Encysive Pharmaceuticals develops synthetic and small molecule compounds to address medical needs worldwide.
Providing new objective data to help clinicians navigate infants to safer and faster independent oral feeding.
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
Sekisui XenoTech is a pharmaceutical company offering pharmaceutical safety testing and drug metabolism services.
Biscayne Pharmaceuticals discovers and develops novel therapies based on growth hormone-releasing hormone (GHRH) analogs.
Revolve Biotechnologies is a biotechnology platform.
As the world's largest fully integrated producer of PA66, we designed our vertically integrated manufacturing process to ensure quality, consistency and supply security. Headquartered in Houston, Texas, Ascend has nine global locations, including five fully integrated manufacturing facilities in the southeastern United States and an engineering plastics compounding facility in Europe, all dedicated to the innovation and safe production of nylon 6,6. With three of the world's largest chemical processing facilities, Ascend's materials form the building blocks for products used in everyday applications from apparel to airbags, cable ties to circuit boards and carpets to car parts. Ascend's 2,500 employees around the world are committed to making a difference in the communities we serve and leading the development of nylon 6,6 solutions that inspire everyone, everywhere, every day. Together, we're making a difference. Together, we're inspiring everyday.
Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.
WRAL TechWire is a technology-specific news publication that provides news and information about high technologies and the life sciences.
Iantech is a developer of a cataract treatment device.
BRAINBox provides objective evidence of injury and prediction of patient recovery.
Evolve Biosystems specializes in providing microbiome-based products designed to develop, restore, and maintain.